The company announced a phase 3…
The company announced a phase 3 win in the rare [...]
While much of the biopharma…
While much of the biopharma industry has spent the past [...]
As the U.S. government intensifies…
As the U.S. government intensifies efforts to acquire Greenland, President [...]
Following an FDA marketing…
Following an FDA marketing suspension, Valneva has decided to voluntarily [...]
Just days after AbbVie unveiled a…
Just days after AbbVie unveiled a major new oncology play [...]
With Fujifilm Biotechnologies now…
With Fujifilm Biotechnologies now among the top echelon of CDMOs [...]
For the fourth year running—and…
For the fourth year running—and the third in a row [...]
Exelixis may only have one drug on…
Exelixis may only have one drug on the market right [...]
On this episode of “The Top Line,”…
On this episode of “The Top Line,” we dig into [...]
New York’s attorney general has…
New York’s attorney general has filed an insider trading lawsuit [...]